PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Coelacanths may live nearly a century, five times longer than researchers expected

Coelacanths may live nearly a century, five times longer than researchers expected
2021-06-17
(Press-News.org) Once thought to be extinct, lobe-finned coelacanths are enormous fish that live deep in the ocean. Now, researchers reporting in the journal Current Biology on June 17 have evidence that, in addition to their impressive size, coelacanths also can live for an impressively long time--perhaps nearly a century.

The researchers found that their oldest specimen was 84 years old. They also report that coelacanths live life extremely slowly in other ways, reaching maturity around the age of 55 and gestating their offspring for five years.

"Our most important finding is that the coelacanth's age was underestimated by a factor of five," says Kélig Mahé of IFREMER Channel and North Sea Fisheries Research Unit in Boulogne-sur-mer, France. "Our new age estimation allowed us to re-appraise the coelacanth's body growth, which happens to be one of the slowest among marine fish of similar size, as well as other life-history traits, showing that the coelacanth's life history is actually one of the slowest of all fish."

Earlier studies attempted to age coelacanths by directly observing growth rings on the scales of a small sample of 12 specimens. Those studies led to the notion that the fish didn't live more than 20 years. If that were the case, it would make coelacanths among the fastest-growing fish given their large size. That seemed surprising considering that the coelacanth's other known biological and ecological features, including slow metabolism and low fecundity, were more typical of fish with slow life histories and slow growth like most other deep-water species.

In the new study, Mahé, along with co-authors Bruno Ernande and Marc Herbin, took advantage of the fact that the French National Museum of Natural History (Muséum National d'Histoire Naturelle de Paris, MNHN) has one of the largest collections of coelacanths in the world, ranging from embryos in utero to individuals of almost two meters. They were able to examine 27 specimens in all. They also used new methods, including polarized light microscopy and scale interpretation technology mastered at IFREMER's Sclerochronology Centre, Boulogne-sur-mer, France, to estimate individuals' age and body growth more precisely than before.

While earlier studies relied on more readily visible calcified structures called macro-circuli to age the coelacanths much as counting growth rings can age a tree, the new approaches allowed the researchers to pick up on much tinier and nearly imperceptible circuli on the scales. Their findings suggest that the coelacanths actually are about five times older than was previously thought.

"We demonstrated that these circuli were actually annual growth marks, whereas the previously observed macro-circuli were not," Mahé says. "It meant that the maximum longevity of coelacanth was five times longer than previously thought, hence around a century."

Their study of two embryos showed they were both about five years old. Using a growth model to back-calculate gestation length based on the size of offspring at birth, the researchers got the same answer. They now think that coelacanth offspring grow and develop for five years inside their mothers prior to birth.

"Coelacanth appears to have one of, if not the slowest life histories among marine fish, and close to those of deep-sea sharks and roughies," Mahé says.

The researchers say that their findings have implications for the coelacanth's conservation and future. They note that the African coelacanth is assessed as critically endangered in the Red List of Threatened Species of IUCN.

"Long-lived species characterized by slow life history and relatively low fecundity are known to be extremely vulnerable to perturbations of a natural or anthropic nature due to their very low replacement rate," Mahé says. "Our results thus suggest that it may be even more threatened than expected due to its peculiar life history. Consequently, these new pieces of information on coelacanths' biology and life history are essential to the conservation and management of this species."

In future studies, they plan to perform microchemistry analyses on coelacanth scales to find out whether a coelacanth's growth is related to temperature. The answer will provide some insight into the effects of global warming on this vulnerable species.

INFORMATION:

Current Biology, Mahé et al.: "New scale analyses reveal centenarian coelacanths Latimeria chalumnae" https://www.cell.com/current-biology/fulltext/S0960-9822(21)00752-1

Current Biology (@CurrentBiology), published by Cell Press, is a bimonthly journal that features papers across all areas of biology. Current Biology strives to foster communication across fields of biology, both by publishing important findings of general interest and through highly accessible front matter for non-specialists. Visit http://www.cell.com/current-biology. To receive Cell Press media alerts, contact press@cell.com.


[Attachments] See images for this press release:
Coelacanths may live nearly a century, five times longer than researchers expected

ELSE PRESS RELEASES FROM THIS DATE:

Slowed cell division causes microcephaly

2021-06-17
The birth of a human being requires billions of cell divisions to go from a fertilised egg to a baby. At each of these divisions, the genetic material of the mother cell duplicates itself to be equally distributed between the two new cells. In primary microcephaly, a rare but serious genetic disease, the ballet of cell division is dysregulated, preventing proper brain development. Scientists from the University of Geneva (UNIGE), in collaboration with Chinese scientists, have demonstrated how the mutation of a single protein, WDR62, prevents the proper formation of the cable network responsible for separating genetic material into two. As cell division is then slowed down, the brain ...

Antibiotic Novobiocin found to kill tumor cells with DNA-repair glitch

2021-06-17
BOSTON - An antibiotic developed in the 1950s and largely supplanted by newer drugs, effectively targets and kills cancer cells with a common genetic defect, laboratory research by Dana-Farber Cancer Institute scientists shows. The findings have spurred investigators to open a clinical trial of the drug, novobiocin, for patients whose tumors carry the abnormality. In a study in the journal Nature Cancer, the researchers found that in laboratory cell lines and tumor models novobiocin selectively killed tumor cells with abnormal BRCA1 or BRCA2 genes, which help repair damaged DNA. The drug was effective even in tumors resistant to agents known as PARP inhibitors, which have become a prime therapy for cancers with DNA-repair glitches. "PARP inhibitors ...

New manufacturing technique for flexible electronics

New manufacturing technique for flexible electronics
2021-06-17
Ultrathin, flexible computer circuits have been an engineering goal for years, but technical hurdles have prevented the degree of miniaturization necessary to achieve high performance. Now, researchers at Stanford University have invented a manufacturing technique that yields flexible, atomically thin transistors less than 100 nanometers in length - several times smaller than previously possible. The technique is detailed in a paper published June 17 in Nature Electronics. With the advance, said the researchers, so-called "flextronics" move closer to reality. Flexible electronics promise bendable, ...

Higher COVID-19 mortality among Black patients linked to unequal hospital quality

2021-06-17
PHILADELPHIA-- The COVID-19 death rate for Black patients would be 10 percent lower if they had access to the same hospitals as white patients, a new study shows. Researchers from the Perelman School of Medicine at the University of Pennsylvania and OptumLabs, part of UnitedHealth Group, analyzed data from tens of thousands of hospitalized COVID-19 patients and found that Black patients died at higher rates than white patients. But the study, published today in JAMA Network Open, determined that didn't have to be the case if more Black patients were able to get care at different hospitals. "Our study reveals that Black patients have worse outcomes largely because they tend to go to worse-performing hospitals," said the study's first author, David Asch, MD, ...

Differences in inpatient mortality among US Black, White patients with COVID-19

2021-06-17
What The Study Did: The findings of this study suggest that the increased mortality among Black patients hospitalized with COVID-19 is associated with the hospitals at which Black patients disproportionately received care. Authors: David A. Asch, M.D., M.B.A., of the University of Pennsylvania in Philadelphia, is the the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.12842) Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, ...

Association of convalescent plasma therapy with survival in patients with blood cancers, COVID-19

2021-06-17
What The Study Did: Researchers evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic (blood) cancers and COVID-19. Authors: Jeremy L.Warner, M.D., M.S., of Vanderbilt University in Nashville, Tennessee, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  (doi:10.1001/jamaoncol.2021.1799) Editor's Note: The article includes conflict of interest and funding/support disclosures. Please ...

COVID-19 symptom incidence among hospital employees for early alert surveillance of hospital admissions

2021-06-17
What The Study Did: This study examined whether mandatory daily employee symptom data collection can be used as an early alert surveillance system to estimate COVID-19 hospitalizations in communities where employees live. Authors: Steven Horng, M.D., M.MSc., of Beth Israel Deaconess Medical Center in Boston, is the the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.13782) Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: The full study ...

Health, economic outcomes associated with COVID-19 in women at high risk of HIV infection in rural Kenya

2021-06-17
What The Study Did: In this survey study, COVID-19 was associated with large reductions in economic security among women at high risk of HIV infection in Kenya. However, shifts in sexual behavior may have temporarily decreased their risk of HIV infection. Authors: Harsha Thirumurthy, Ph.D., of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, is the the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.13787) Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, ...

Survival of very preterm infants discharged against medical advice in China

2021-06-17
What The Study Did: Researchers estimated survival and other outcomes of very preterm infants in China discharged against medical advice from neonatal intensive care units before complete care can be provided compared with infants who receive full intensive care treatment. Authors: Yun Cao, M.D., Ph.D., and Weili Yan, Ph.D., of Children's Hospital of Fudan University in Shanghai, China, are the corresponding authors. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.13197) Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest ...

Study validates a highly sensitive molecular test to detect cases of Tubercul

2021-06-17
The 'Xpert Ultra' molecular test has a greater capacity than its predecessor ('Xpert MTB/RIF') in detecting tuberculosis cases, either passively (i.e. people who attend the hospital with disease symptoms) or actively (searching for possible cases in the community among contacts of cases). This is the main conclusion of a study performed by ISGlobal, an institution supported by "la Caixa" Foundation, in collaboration with the Manhiça Health Research Centre (CISM), published in the European Respiratory Journal. Tuberculosis (TB) is the leading cause of death by an infectious agent, worldwide. In 2019, 1.4 million people are estimated to have died and 10 million people fell sick from TB, although only 70% of the cases were diagnosed. ...

LAST 30 PRESS RELEASES:

The threat of polio paralysis may have disappeared, but enterovirus paralysis is just as dangerous and surveillance and testing systems are desperately needed

Study shows ChatGPT failed when challenging ESCMID guideline for treating brain abscesses

Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

[Press-News.org] Coelacanths may live nearly a century, five times longer than researchers expected